LDN 2018 Conference - Q&A Session 1 (LDN, low dose naltrexone)

 

LDN 2018 Conference - Q&A Session 2 (LDN, low dose naltrexone)

 

Stephen Dickson, BSC (hons) MRPharmS - Using an Old Drug to Trick the Immune System into Healing Itself (2018 Conference) (LDN, low dose naltrexone)

 

Mark Cooper, PhD - LDN, Neuroinflammation, and Movement Disorders (2018 Conference) (LDN, low dose naltrexone)

 

John Bardsley - Using unlicensed medicines as a part of patient care (2018 Conference) (LDN, low dose naltrexone)

John Bardsley is a pharmacist who has spent 15 years in the supply chain managing small to medium sized businesses in terms of GMP manufacture and GDP distribution throughout the UK. 

 

Sarah Zielsdorf, MD, MS - Traumatic Brain Injury: Low Dose Naltrexone and Microglial Modification (2019 Conference) (LDN, low dose naltrexone)

 

Sarah Zielsdorf, MD, MS - Rheumatoid Arthritis (2018 Conference) (LDN, low dose naltrexone)

Dr Sarah Zielsdorf shares her presentation on Rheumatoid Arthritis (RA) at The LDN 2018 Conference.

In this presentation Dr Zielsdorf presents a fascinating case study of a patient with Rheumatoid Arthritis (RA) detailing her experience with symptoms, statistics and her own wealth of medical experience.

 

Nasha Winters, ND - The Low Down on LDN (2017 Conference) (LDN, low dose naltrexone)

In this presentation Dr Winters talks about the history of Low Dose Naltrexone (LDN) and recounts its remarkable story in terms of treatment in HIV patients and the positive effects it can have on immunodeficient patients.

 

Leonard Weinstock, MD - Low Dose Naltrexone and Sarcoidosis Therapy (2018 Conference) (LDN, low dose naltrexone)

Dr Leonard Weinstock is from St Louis in Missouri and helps patients with GI Issues and other autoimmune conditions.

 

Dana Flavin, MD - Reversing Cancer with Biochemistry (2018 Conference) (LDN, low dose naltrexone)

Dr Dana Flavin shares her presentation on Reversing Cancer at the LDN 2018 Conference.